Skip to content

    AbbVie Inc.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $14.46B
    $14.46B
    $15.10B
    $13.34B
    $15.42B
    +6.6%
    $15.78B
    +9.1%
    $16.62B
    +10.0%
    $15.00B
    +12.4%
    Strengthening
    Operating Profit
    $4.00B
    $3.83B
    -$1.49B
    $3.73B
    $4.89B
    +22.4%
    $1.90B
    -50.3%
    $4.54B
    $3.99B
    +6.9%
    Weakening
    Net Profit
    $1.37B
    $1.56B
    -$22.00M
    $1.29B
    $938.00M
    -31.5%
    $186.00M
    -88.1%
    $1.82B
    $695.00M
    -46.0%
    Weakening
    EPS
    $0.77
    $0.88
    $-0.02
    $0.72
    $0.52
    -32.5%
    $0.10
    -88.6%
    $1.02
    $0.39
    -45.8%
    Weakening
    Other Income
    Interest
    $726.00M
    $720.00M
    $702.00M
    $700.00M
    $740.00M
    +1.9%
    $739.00M
    +2.6%
    $714.00M
    +1.7%
    $717.00M
    +2.4%
    Stable
    Depreciation
    Profit before Tax
    $2.15B
    $2.08B
    -$2.27B
    $1.66B
    $1.55B
    -27.6%
    $714.00M
    -65.7%
    $2.67B
    $1.04B
    -37.4%
    Weakening
    MarginsOPM
    27.6%
    26.5%
    -9.9%
    28.0%
    31.7%
    +14.8%
    12.1%
    -54.4%
    27.3%
    26.6%
    -4.9%
    Weakening
    Tax
    36.0%
    24.9%
    99.0%
    22.4%
    39.5%
    +9.5%
    73.7%
    +195.3%
    32.0%
    -67.7%
    32.9%
    +47.0%
    Strengthening
    ReturnsROIC
    -7.7%
    -8.7%
    0.1%
    -7.2%
    -5.2%
    +31.5%
    -1.0%
    +88.1%
    -10.2%
    -8354.5%
    -3.9%
    +46.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$7.29B$39.92B$8.45B$9.75B$9.20B$12.81B$5.52B$5.23B$9.39B
    Short-Term Investments
    Total Current Assets$16.95B$49.52B$24.17B$27.93B$28.46B$33.00B$25.58B$29.06B$33.53B
    Net PP&E$2.88B$2.96B$6.14B$5.87B$5.67B$5.73B$5.86B$6.37B$5.69B
    Goodwill$15.66B$15.60B$33.12B$32.38B$32.16B$32.29B$34.96B$35.64B$35.57B
    Intangibles$21.23B$18.65B$82.88B$75.95B$67.44B$55.61B$60.07B$52.64B$50.87B
    Total Assets$59.35B$89.11B$150.56B$146.53B$138.81B$134.71B$135.16B$133.96B$136.46B
    LiabilitiesTotal Current Liabilities$17.24B$15.59B$28.66B$35.19B$29.54B$37.84B$38.75B$43.29B$42.10B
    Short-Term Debt$3.70B$0$34.00M$14.00M$1.00M$0$0$2.50B$0
    Long-Term Debt$67.23B$84.95B$75.96B$63.13B$59.24B$66.84B$64.50B
    Long-Term Leases$832.00M$713.00M$754.00M$735.00M$697.00M$689.00M
    Total Liabilities$67.80B$97.29B$137.47B$131.09B$121.52B$124.31B$131.80B$137.19B$143.07B
    EquityCommon Stock & APIC
    Retained Earnings$3.37B$4.72B$1.05B$3.13B$4.78B-$1.00B-$7.90B-$15.49B-$17.87B
    Total Equity-$8.45B-$8.17B$13.08B$15.41B$17.25B$10.36B$3.33B-$3.27B-$6.66B
    HighlightsNet Cash / (Debt)-$27.31B-$76.53B-$66.23B-$53.93B-$46.43B-$61.32B-$61.77B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$13.43B$13.32B$17.59B$22.78B$24.94B$22.84B$18.81B$19.03B$21.22B
    Cash from Investing-$1.01B$596.00M-$37.56B-$2.34B-$623.00M-$2.01B-$20.82B-$6.64B-$6.48B
    Cash from Financing-$14.40B$18.71B-$11.50B-$19.04B-$24.80B-$17.22B-$5.21B-$12.72B-$10.55B
    SummaryCapital Expenditure-$638.00M-$552.00M-$798.00M-$787.00M-$695.00M-$777.00M-$974.00M-$1.21B-$1.24B
    Free Cash Flow$12.79B$12.77B$16.79B$21.99B$24.25B$22.06B$17.83B$17.82B$19.98B
    FCF Margin39.0%38.4%36.7%39.1%41.8%40.6%31.7%29.1%31.8%